TORONTO--()--GreeneStone Healthcare Corporation (OTCBB: GRST), provider of Mental Healthcare and Corporate Healthcare Services, today announced the hiring of Ann Kerr as Clinical Director at its new Eating Disorder clinic. In addition to Ms. Kerr, the Company has chosen a psychiatrist medical director, head psychologist, and Chief Clinical Advisor, all of whom will formally be announced once they are under contract. In addition the recently announced new hire, Dr. Mohsina Chaklader, at the company’s ‘Center of Excellence for Gastroenterology’ will be a valuable resource for the Eating Disorder clinic.
“These are by far the largest component of corporate healthcare costs”
In the United States, as many as 10 million females and 1 million males are suffering from an eating disorder such as anorexia and bulimia and millions more are struggling with binge eating disorders. While awareness of eating disorders is improving, the public, health care providers and educators frequently have little understanding of eating disorders, how to recognize symptoms and how to communicate with people dealing with eating disorders. Eating disorders are very difficult to treat and can require lifelong treatment. The goal of the Company will be to stay with and support patients throughout their time of need, while striving to achieve sufficient improvement so that in-patient care is reduced and outpatient and ongoing care can begin.
Corporate Healthcare and disability costs are growing steadily higher and effective treatment for those suffering from mental health and mental health related issues will be the solution to reducing those costs. The Company has an increasing number of specialists in the treatment of mental health related disorders. “These are by far the largest component of corporate healthcare costs,” stated Mr. Shawn Leon, CEO. He added, “We see this as the biggest area of growth for the Company and we need to be national in scope.”
Ann Kerr is a Registered Occupational Therapist and holds academic appointments as Assistant Professor in the Department of Psychiatry, and Lecturer in the Department of Occupational Therapy in the Faculty of Medicine at The University of Toronto. She has worked in the field of mental health for over 30 years and specialized in the care for people affected by eating disorders through work in Inpatient, Day Hospital, community, and private practice settings. Ann was part of the team that built the Inpatient Eating Disorder Program at Toronto General Hospital under Dr. Sid Kennedy, and then the first ever Eating Disorder Day Hospital Program with Drs Allan Kaplan and Niva Piran. Ann accepted the position of the first Program Director of Sheena’s Place, an innovative model of support services for families and people with eating disorders. Ann has been in private practice in Toronto for the past six years honing her psychotherapy skills in the areas of CBT, DBT and Relational Therapy.
Ann was trained at The University of Toronto and has ongoing education through Harvard Medical School of Continuing Education and the Jean Baker Miller Centre at Wellesley College. She has supervised students in most health professions and been awarded the Northrop Frye teaching award for medical student education. Ann was on the Board of the Transitional College of Occupational Therapists and is a Member of the College of Occupational Therapists of Ontario and the Ontario Association of Occupational Therapists. She is a member of the Academy of Eating Disorders, an international body of eating disorder clinicians and researchers. Ann has written research articles and chapters in books on the treatment of people with eating disorders as well as having spoken at numerous conferences in Canada and the USA. She has appeared frequently on television, radio and in newspapers and magazines commenting on current issues in the culture that relate to this issue.
Limited operations at the Eating Disorder clinic are set to begin in late October, with full service operations intended to commence in early 2013. The primary mission of the clinic will be to treat anorexia and bulimia through a combination of services, including in-patient care, intensive outpatient care, ongoing support, after-care and counseling. The company plans to offer the very best in care and hopes to earn a reputation for the best care available in the country.
About GreeneStone Healthcare Corporation
GreeneStone Healthcare Corp. (OTCBB: GRST) is a provider of mental health services, specializing in the areas of addiction treatment, eating disorders, nutrition and weight loss, and executive healthcare. GreeneStone is among the many nascent healthcare companies re-defining the healthcare space for the modern economy, which include Roche Holding Ltd. (OTCQB: RHHBY), Sarepta Therapeutics Inc. (NASDAQ: SRPT), Nektar Therapeutics (NASDAQ: NKTR), Celldex Therapeutics, Inc. (NASDAQ: CLDX), Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Zogenix, Inc. (NASDAQ: ZGNX). The company operates medical and healthcare clinics in Ontario, Canada, serving a North American and international clientele. GreeneStone’s clinics meet several ends: (1) GreeneStone adds overflow capacity to an increasingly stretched public healthcare system in Canada, (2) GreeneStone mental health clinics provide private alternatives to publicly available but highly underserviced healthcare subsectors, and (3) GreeneStone meets newly developing healthcare needs undisturbed by the public/private market, such as eating disorders. The company is headquartered in Toronto, Canada.
Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). To the extent that any statements made in this press release contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as “expect,” “plan,” “will,” “may,” “anticipate,” “believe,” “should,” “intend,” “estimate,” and variations of such words. Forward-looking statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, those risks and uncertainties contained in this press release and those identified in the periodic reports that the company files with the Securities and Exchange Commission (the “SEC”) pursuant to the Exchange Act.
Investor information and email sign-up: